Organoid technologies have become a powerful emerging tool to model liver diseases, for drug screening, and for personalized treatments. Assoc. Prof. Tamer Önder of Koç University and his team generated and characterized the hepatic organoid culture system using human induced pluripotent stem cell (iPS) as an intermediate.
Click here for original story, Organoids: The future of disease modelling?
Source: Phys.org